efinopegdutide
offering product urn:matchory:offering:01m772jz8bfmftaxmna0dse0jt
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: 51181500 Antidiabetic agents and hyperglycemic agents (class).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | efinopegdutide | products products 2 | efinopegdutidehttps://www.merck.com/research/product-pipeline/ |
2026-11-12 | current |
| Name as stated name | Efinopegdutide | products products 2 | Merck Announces Positive Results from Phase 2b Trial of Efinopegdutidehttps://www.merck.com/investor-relations/ |
2026-11-12 | current |
| Name as stated name | efinopegdutide | extraction extract 3 | efinopegdutidehttps://www.merck.com/research/product-pipeline/ |
2026-11-12 | current |
| Name as stated name | Efinopegdutide | extraction extract 3 | Efinopegdutidehttps://www.merck.com/investor-relations/ |
2026-11-12 | current |
| UNSPSC classification unspsc | 51181500 (16 candidates considered) (0.84) | classification unspsc 3 | 2026-11-12 | current |